Regulatory Approval

News Regulatory Approval

  • QIAGEN and Abbott Enter Into Agreement on Molecular Tests for HIV, HCV and HPV

    QIAGEN and Abbott announced that they have entered into an agreement that significantly strengthens both companies’ testing menus for automated in-vitro diagnostic applications in the United States and Canada. Financial terms were not disclosed. Under the terms of the agreements, QIAGEN will receiv more

  • Zetiq Technologies and Biomics Biotechnologies Sign Collaboration Agreement

    Bio-Light announces the signing of a collaboration agreement between its subsidiary, Zetiq Technologies, and the Chinese company, Biomics Biotechnologies, whose expertise lies in the development and sales of medical and diagnostic products. This follows a memorandum of understanding signed between t more

  • ITT agrees to purchase Nova Analytics

    ITT Corporation announced its agreement to purchase Nova Analytics Corporation. Nova Analytics is a privately held manufacturer of premium quality laboratory, field, portable, and on-line analytical instruments used in water and wastewater, environmental, medical, and food and beverage applications. more

All news on regulatory approval

Websites Regulatory Approval

PAREXEL International

Careers News and Events Investors     PAREXEL CHAIRMAN AND CEO NAMED EXECUTIVE OF THE YEAR IN NORTH AMERICA IN INTERN... PAREXEL EXPERTS TO PRESENT INSIGHTS INTO SUCCESSFUL GLOBAL PRODUCT DEVELOPMENT ... PAREXEL ANNOUNCES DATE OF FOURTH QUARTER AND FISCAL YEAR 2010 EARNINGS RELEASE A... PAREXEL CONS more

ir_news_17Mar2010.html

>   HOME >   CONTACT CORPORATE Profile Leadership In the News Careers RESEARCH Technology Market Indications Publications PRODUCT DEVELOPMENT Development Status Davunetide intranasal Davunetide intravenous Pre-clinical Partnering INVESTOR RELATIONS News Releases Investment Highlights Shareholder Rep more

Microsoft Word - 11.11.10 BMR Q3 Results News Release clean.doc

FOR IMMEDIATE RELEASE TSX: BMR BRADMER ANNOUNCES 2009 THIRD QUARTER FINANCIAL RESULTS Toronto, Ontario – November 12, 2009 – Bradmer Pharmaceuticals Inc. (“Bradmer” or the “Company”) today announced its 2009 third quarter financial results. Operational Highlights D more

All websites on regulatory approval
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE